44. 多発血管炎性肉芽腫症 [臨床試験数:84,薬物数:88(DrugBank:22),標的遺伝子数:13,標的パスウェイ数:37

Searched query = "Wegener granulomatosis", "Multiple vasculitis granulomatous disease", "Granulomatosis with polyangiitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01405807
(ClinicalTrials.gov)
February 201127/7/2011Alemtuzumab for ANCA Associated Refractory VasculitisAlemtuzumab for ANCA Associated Refractory Vasculitis - a Study of Safety and EfficacyVasculitis;Microscopic Polyangiitis;Granulomatosis With Polyangiitis;Wegener'sDrug: AlemtuzumabCambridge University Hospitals NHS Foundation TrustNULLRecruiting18 Years60 YearsBoth24Phase 4United Kingdom